Authors | Country | Year | Study design | Patients/fractures (n) | Mean age (years) (range) | Number of AVN | Incidence rate (%) | NOS/IHE score |
---|---|---|---|---|---|---|---|---|
Li [25] | China | 2022 | Case–control | 28 | 9.4 (6.2–12.1) | 6 | 21.4 | 7a |
Wu [26] | China | 2020 | Case–control | 16/17 | 10.4 (1–14) | 4 | 23.53 | 7a |
Singh [36] | India | 2020 | Case–control | 32/34 | 11.7 (4–17) | 4 | 11.76 | 8a |
Dai [27] | China | 2020 | Case–control | 44 | 9 (2–14) | 14 | 31.82 | 8a |
Wang [10] | China | 2019 | Case–control | 239/241 | 10 | 59 | 24.48 | 8a |
Spence [12] | USA | 2016 | Case–control | 70 | 13.2 (1.3–18.1) | 20 | 28.57 | 7a |
Liu [28] | China | 2016 | Case series | 21 | 15.3 (14–18) | 1 | 4.76 | 13b |
Stone [32] | USA | 2015 | Case–control | 22 | 11.5 (4.5–17.4) | 8 | 36.36 | 7a |
Patrick [33] | USA | 2015 | Case–control | 43/44 | 0.9–17 | 9 | 20.45 | 6a |
Bukva [39] | Serbia | 2015 | Case–control | 28 | 10.7 (4–14) | 11 | 39.29 | 6a |
Hajdu [40] | Austria | 2011 | Cross-sectional | 8 | 11.6 (3–15) | 1 | 12.50 | 9a |
Bali [37] | India | 2011 | Case series | 36 | 10 (3–16) | 7 | 19.44 | 11b |
Dendane [41] | Morocco | 2010 | Case series | 21 | 12.1 (5–16) | 7 | 33.33 | 13b |
Inan [16] | Turkey | 2009 | Case–control | 39 | 11.1 (4–16) | 11 | 28.21 | 8a |
Varshney [15] | India | 2009 | Case–control | 21 | 11.8 (5–15) | 3 | 14.29 | 8a |
Qi [29] | China | 2008 | Case series | 23 | 10.2 (5–16) | 3 | 13.04 | 11b |
Shrader [14] | USA | 2007 | Case series | 20 | 11 (4–15) | 2 | 10.00 | 15b |
Togrul [38] | Turkey | 2005 | Cross-sectional | 61/62 | 10.2 (2–14) | 9 | 14.52 | 10b |
Mirdad [42] | Saudi Arabia | 2002 | Case series | 14 | 9.1 (4–16) | 7 | 50.00 | 9b |
Flynn [34] | USA | 2002 | Case series | 18 | 8 (2–13) | 1 | 5.56 | 11b |
Bagatur [5] | Turkey | 2002 | Case series | 17 | 11 (7–14) | 9 | 52.94 | 9b |
Song [9] | USA | 2001 | Case series | 13 | 5–16 | 0 | 0.00 | 10b |
Morsy [43] | Egypt | 2001 | Case series | 53 | 10.2 (3–16) | 21 | 39.62 | 9b |
Pape [44] | Germany | 1999 | Case series | 28 | 11.8 (1–15) | 3 | 10.71 | 12b |
Cheng [30] | China | 1999 | Case series | 14 | 3–16 | 0 | 0.00 | 12b |
Ng [45] | Canada | 1996 | Retrospective cohort | 32 | 9.5 ± 5 | 9 | 28.13 | 8a |
Davison [2] | USA | 1992 | Case series | 19 | 11 (1–16) | 9 | 47.37 | 8b |
Canale [35] | USA | 1977 | Case series | 60/61 | 9.7 (0.5–17) | 26 | 42.62 | 8b |
Lam [31] | China | 1971 | Case series | 75 | 0.7–17 | 11 | 14.67 | 10b |
Ratliff [20] | UK | 1962 | Case series | 71 |  < 17 | 30 | 42.25 | 9b |